Brenda Libby Coleman

Array ( [id] => 4147285 [patent_doc_number] => 06063779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => '5-(4-piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents' [patent_app_type] => 1 [patent_app_number] => 9/079861 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4720 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063779.pdf [firstpage_image] =>[orig_patent_app_number] => 079861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135197 [patent_doc_number] => 06147220 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Process to 5-methyleneoxazolines' [patent_app_type] => 1 [patent_app_number] => 9/079639 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4361 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147220.pdf [firstpage_image] =>[orig_patent_app_number] => 079639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141151 [patent_doc_number] => 06060479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Quinazoline-4-one AMPA antagonists' [patent_app_type] => 1 [patent_app_number] => 9/079419 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9782 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060479.pdf [firstpage_image] =>[orig_patent_app_number] => 079419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132009 [patent_doc_number] => 06034082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => '5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/074931 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9225 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034082.pdf [firstpage_image] =>[orig_patent_app_number] => 074931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356502 [patent_doc_number] => 06200986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Hemoregulatory compounds' [patent_app_type] => 1 [patent_app_number] => 9/068488 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3047 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200986.pdf [firstpage_image] =>[orig_patent_app_number] => 068488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288886 [patent_doc_number] => 06211214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Biphenyl ether oxazolines and their use as pest-control agents' [patent_app_type] => 1 [patent_app_number] => 9/068819 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10128 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211214.pdf [firstpage_image] =>[orig_patent_app_number] => 068819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418700 [patent_doc_number] => 06194413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Hemoregulatory compounds' [patent_app_type] => 1 [patent_app_number] => 9/068490 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3118 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194413.pdf [firstpage_image] =>[orig_patent_app_number] => 068490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185944 [patent_doc_number] => 06159995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Substituted diaminocarboxylic acids' [patent_app_type] => 1 [patent_app_number] => 9/074587 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159995.pdf [firstpage_image] =>[orig_patent_app_number] => 074587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237942 [patent_doc_number] => 06143772 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof' [patent_app_type] => 1 [patent_app_number] => 9/066365 [patent_app_country] => US [patent_app_date] => 1998-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3215 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143772.pdf [firstpage_image] =>[orig_patent_app_number] => 066365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435997 [patent_doc_number] => 06355640 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Pyrazolopyridine adenosine antagonists' [patent_app_type] => B1 [patent_app_number] => 09/072696 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40244 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355640.pdf [firstpage_image] =>[orig_patent_app_number] => 09072696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115810 [patent_doc_number] => 06046211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Amidino derivatives useful as nitric oxide synthase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/073929 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 35897 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046211.pdf [firstpage_image] =>[orig_patent_app_number] => 073929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260532 [patent_doc_number] => 06204267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds' [patent_app_type] => 1 [patent_app_number] => 9/071682 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18030 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204267.pdf [firstpage_image] =>[orig_patent_app_number] => 071682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4139132 [patent_doc_number] => 06015898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Processes and compositions for nitration of N-substituted isowurtzitane compounds with concentrated nitric acid at elevated temperatures to form HNIW and recovery of gamma HNIW with high yields and purities' [patent_app_type] => 1 [patent_app_number] => 9/071022 [patent_app_country] => US [patent_app_date] => 1998-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3797 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015898.pdf [firstpage_image] =>[orig_patent_app_number] => 071022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088708 [patent_doc_number] => 06025495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Regioselective alkylation process for preparing substituted benzo[b]thiophenes' [patent_app_type] => 1 [patent_app_number] => 9/069276 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3935 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025495.pdf [firstpage_image] =>[orig_patent_app_number] => 069276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947332 [patent_doc_number] => 05998464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => '4-Oxa and 4-thia steroids' [patent_app_type] => 1 [patent_app_number] => 9/065112 [patent_app_country] => US [patent_app_date] => 1998-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15285 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 468 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998464.pdf [firstpage_image] =>[orig_patent_app_number] => 065112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288419 [patent_doc_number] => 06211183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Selective factor Xa inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/058564 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13595 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211183.pdf [firstpage_image] =>[orig_patent_app_number] => 058564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260548 [patent_doc_number] => 06204268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Selective factor Xa inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/058565 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15788 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204268.pdf [firstpage_image] =>[orig_patent_app_number] => 058565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446889 [patent_doc_number] => 06369063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Selective factor Xa inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/058821 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14666 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369063.pdf [firstpage_image] =>[orig_patent_app_number] => 09058821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089388 [patent_doc_number] => 06133256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Selective factor Xa inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/058566 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12474 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133256.pdf [firstpage_image] =>[orig_patent_app_number] => 058566 [rel_patent_id] =>[rel_patent_doc_number] =>)